Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNHC
4426
DELISTED
FedNat Holding Company Common Stock
FNHC
| $393K | ﹤0.01% |
23,641
+9,027
| +62% | +$135K |
|
|
ECOM
4427
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $392K | ﹤0.01% |
43,385
+29,996
| +224% | +$275K |
|
4428
PUT
Coeur Mining
CDE
$16.7B
| $389K | ﹤0.01% |
48,100
+26,900
| +127% | +$166K |
|
4429
PUT
Zimmer Biomet
ZBH
$18.5B
| $389K | ﹤0.01% |
2,678
+1,133
| +73% | +$156K |
|
|
ZIXI
4430
DELISTED
Zix Corporation
ZIXI
| $389K | ﹤0.01% |
57,456
+11,873
| +26% | +$82.1K |
|
|
DX
4431
Dynex Capital
DX
$3.17B
| $388K | ﹤0.01% |
22,927
-61,449
| -73% | -$992K |
|
4432
Energy Recovery
ERII
$470M
| $388K | ﹤0.01% |
39,639
+16,125
| +69% | +$149K |
|
4433
CALL
Landstar System
LSTR
$6.16B
| $387K | ﹤0.01% |
3,400
+100
| +3% | +$11.3K |
|
4434
PUT
Paylocity
PCTY
$7.67B
| $387K | ﹤0.01% |
3,200
-4,100
| -56% | -$449K |
|
|
KRTX
4435
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $387K | ﹤0.01% |
5,137
+2,879
| +128% | +$126K |
|
|
CSTR
4436
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $386K | ﹤0.01% |
23,151
+15,743
| +213% | +$263K |
|
4437
Green Brick Partners
GRBK
$3.1B
| $385K | ﹤0.01% |
33,638
+21,297
| +173% | +$233K |
|
4438
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $385K | ﹤0.01% |
4,060
| – | – |
|
4439
SmartFinancial
SMBK
$910M
| $385K | ﹤0.01% |
16,283
+9,825
| +152% | +$216K |
|
4440
Vera Bradley
VRA
$99M
| $385K | ﹤0.01% |
32,586
-6,450
| -17% | -$71.5K |
|
|
IMDX
4441
Insight Molecular Diagnostics
IMDX
$165M
| $384K | ﹤0.01% |
8,537
+8,007
| +1,511% | +$289K |
|
4442
Garrett Motion
GTX
$5.86B
| $383K | ﹤0.01% |
38,335
-246,452
| -87% | -$2.51M |
|
4443
Heritage Insurance Holdings
HRTG
$902M
| $383K | ﹤0.01% |
28,985
+10,396
| +56% | +$143K |
|
4444
NGL Energy Partners
NGL
$1.98B
| $382K | ﹤0.01% |
33,703
-104,102
| -76% | -$1.16M |
|
|
ATCO
4445
CALL
DELISTED
Atlas Corp.
ATCO
| $382K | ﹤0.01% |
26,900
+10,800
| +67% | +$129K |
|
4446
Surgery Partners
SGRY
$2.05B
| $381K | ﹤0.01% |
24,367
+5,073
| +26% | +$57.5K |
|
4447
Domo
DOMO
$181M
| $380K | ﹤0.01% |
17,511
-24,524
| -58% | -$453K |
|
|
RAD
4448
CALL
DELISTED
Rite Aid Corporation
RAD
| $380K | ﹤0.01% |
24,570
-22,515
| -48% | -$220K |
|
4449
Howard Hughes
HHH
$3.91B
| $379K | ﹤0.01% |
3,135
-8,391
| -73% | -$931K |
|
|
DSSI
4450
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $379K | ﹤0.01% |
22,684
+11,175
| +97% | +$167K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.